Cellular and Molecular Biology

National Cancer Institute, NIH, 2001-2002
Advisor: David Gius, PhD, MD
Project: Continued undergraduate research and more extensively studied components of the pathways

Washington University in St. Louis, 1998 - 2001
Advisor: David Gius, PhD, MD
Project: Researched the effects of ionizing radiation, certain chemotherapies, and radio- and chemo- sensitizing agents on tumor cell signalling pathways

Role of NF-B in Multiple Myeloma

Simonson WT, Markovina S, Grossman WJ, Lokuta MA, Doan AT, Seroogy CM, Huttenlocher A. 2009. Common variable immunodeficiency with regulatory T-cell deficiency treated with rapamycin. Ann Allergy Asthma Immunol 102:170-1.

Markovina S, Callander NS, O'Connor SL, Kim J, Werndli JE, Raschko M, Leith CP, Kahl BS, Kim K, Miyamoto S. 2008. Bortezomib-resistant nuclear factor-kappaB activity in multiple myeloma cells. Mol Cancer Res 6:1356-64. PMCID: 2587345

Yang DT, Young KH, Kahl BS, Markovina S, Miyamoto S. 2008. Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma. Mol Cancer 7:40. PMCID: 2408930

O'Connor S, Markovina S, Miyamoto S. 2005. Evidence for a phosphorylation-independent role for Ser 32 and 36 in proteasome inhibitor-resistant (PIR)ï?  degradation in B cells. Exp Cell Res 307:15-25.